Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220004295 220001745 null null Disease modification (D) null 2014-10-17 Hydroxycarbamide N N 220025740 HYDROXYCARBAMIDE
220004296 220018638 1.62 null Curative (C) 2016-08-07 2016-08-13 Azacitidine N N 220025748 AZACITIDINE
220004297 220018638 1.65 108 Disease modification (D) 2015-10-08 2015-10-23 Azacitidine 02 N 220025748 AZACITIDINE
220004298 220018638 null 84.8 Palliative (P) 2014-01-05 2014-02-09 Azacitidine N N 220025748 AZACITIDINE
220004299 220001746 1.62 78.8 Palliative (P) 2013-04-22 2013-04-22 Azacitidine N N 220025756 AZACITIDINE
220004300 220001746 1.6 null null 2015-08-08 2015-08-08 Azacitidine 99 null 220025756 AZACITIDINE
220004301 220001747 1.78 72.7 null 2013-12-24 2014-01-02 Azacitidine 02 N 220025762 AZACITIDINE
220004302 220001747 1.7 71 Palliative (P) 2014-12-14 2014-12-14 Azacitidine N null 220025762 AZACITIDINE
220004303 220015781 0 71.2 Palliative (P) 2013-06-01 2013-06-01 Hydroxycarbamide 2 N 220025767 HYDROXYCARBAMIDE
220004304 220015781 0 0 Palliative (P) 2014-07-06 2014-07-07 Hydroxycarbamide N N 220025767 HYDROXYCARBAMIDE
220004305 220015781 1.72 56.3 Curative (C) 2016-10-25 2016-10-28 Hydroxycarbamide 02 N 220025767 HYDROXYCARBAMIDE
220004306 220015781 null 73.9 Palliative (P) 2016-04-14 2016-04-18 Azacitidine null N 220025767 AZACITIDINE
220004307 220015781 null null Palliative (P) 2014-07-04 2014-07-04 Hydroxycarbamide N null 220025767 HYDROXYCARBAMIDE
220004308 220015781 1.77 null Not known (9) 2015-01-19 2015-01-19 Azacitidine 2 null 220025767 AZACITIDINE
220004309 220001748 1.72 65 Disease modification (D) 2014-12-29 2015-01-11 Azacitidine N N 220025786 AZACITIDINE
220004310 220001749 null -1 Curative (C) 2017-10-27 2017-10-27 Azacitidine 2 null 220025788 AZACITIDINE
220004311 220001749 0 null Disease modification (D) 2015-06-14 2015-06-14 Hydroxycarbamide N N 220025788 HYDROXYCARBAMIDE
220004312 220001749 1.72 102.8 null 2015-01-20 2015-01-20 Azacitidine N N 220025788 AZACITIDINE
220004313 220001749 1.71 78 Disease modification (D) 2016-03-16 2016-03-17 Azacitidine 2 N 220025788 AZACITIDINE
220004314 220001750 1.68 123.1 Palliative (P) 2015-12-30 2016-01-14 Azacitidine 02 Y 220025792 AZACITIDINE
220004315 220010865 null 83.5 Disease modification (D) 2017-07-26 2017-08-08 Azacitidine 2 N 220025793 AZACITIDINE
220004316 220010865 1.8 90.6 Curative (C) 2017-10-07 2017-10-21 Azacitidine N N 220025793 AZACITIDINE
220004317 220010865 1.56 108 Curative (C) 2013-03-15 2013-03-15 Azacitidine 99 N 220025793 AZACITIDINE
220004318 220001751 0 78.6 Curative (C) 2013-02-13 2013-02-13 AML17 TRIAL Y N 220025799 AML17 TRIAL
220004319 220001751 1.69 59.6 Curative (C) 2017-11-16 2017-11-16 AML17 TRIAL 1 N 220025799 AML17 TRIAL
220004320 220001752 1.81 55 Curative (C) 2016-07-29 2016-07-29 AML17 TRIAL Y N 220025802 AML17 TRIAL
220004321 220010867 null null null 2017-11-09 2017-11-09 Cytarabine low (10to20mg/m2) IV/SC 2 N 220025803 CYTARABINE
220004322 220010867 1.71 null Curative (C) 2014-11-17 2014-11-22 AML17 TRIAL N N 220025803 AML17 TRIAL
220004323 220010867 null 89 Disease modification (D) 2013-10-24 2013-10-25 Trial Unspecified Y N 220025803 TRIAL
220004324 220010867 1.7 71.8 Curative (C) 2015-10-11 2015-10-11 LI-1 TRIAL Y null 220025803 TRIAL
220004325 220010867 1.7 59.2 Curative (C) 2014-03-30 2014-03-30 Trial Unspecified Y N 220025803 TRIAL
220004326 220010867 1.75 97.1 Not known (9) 2014-10-11 2014-11-15 Trial Unspecified Y N 220025803 TRIAL
220004327 220010867 1.64 66.9 Curative (C) 2013-11-26 2013-11-26 LI-1 TRIAL 1 N 220025803 TRIAL
220004328 220010867 null 83.5 Palliative (P) 2015-07-27 2015-07-27 Cytarabine Low Dose 02 N 220025803 CYTARABINE
220004329 220010867 1.6 null Palliative (P) 2016-03-02 2016-03-02 Cytarabine Low Dose N N 220025803 CYTARABINE
220004330 220001753 null 70.5 Curative (C) 2015-02-03 2015-02-06 Trial Unspecified 01 null 220025825 TRIAL
220004331 220001754 1.62 79.25 Curative (C) 2017-10-29 2017-11-03 Trial Unspecified N N 220025827 TRIAL
220004332 220001754 1.8 78 Curative (C) 2013-10-25 2013-10-25 AML17 TRIAL Y N 220025827 AML17 TRIAL
220004333 220001754 1.86 null Curative (C) null 2018-01-08 Cytarabine Low Dose N null 220025827 CYTARABINE
220004334 220001754 0 60.9 Not known (9) 2017-06-12 2017-06-12 AML17 TRIAL 1 null 220025827 AML17 TRIAL
220004335 220001755 1.5 85 Curative (C) 2014-02-25 2014-02-25 AML17 TRIAL 02 N 220025839 AML17 TRIAL
220004336 220001755 0 46 Curative (C) 2014-08-07 2014-08-07 AML17 TRIAL Y N 220025839 AML17 TRIAL
220004337 220015786 null 83 null null 2013-08-26 AML17 TRIAL Y null 220025843 AML17 TRIAL
220004338 220015786 1.82 106.3 Disease modification (D) 2016-07-13 2016-07-13 Trial Unspecified Y N 220025843 TRIAL
220004339 220015786 1.77 79 Curative (C) 2014-05-13 2014-05-14 Trial Unspecified Y N 220025843 TRIAL
220004340 220001756 1.54 53.3 Palliative (P) 2017-12-28 2017-12-29 Cytarabine Low Dose 2 N 220025847 CYTARABINE
220004341 220001756 1.87 null Curative (C) 2013-12-22 2013-12-22 AML17 TRIAL 1 N 220025847 AML17 TRIAL
220004342 220001756 1.81 79.8 null 2015-04-24 2015-04-29 AML17 TRIAL Y N 220025847 AML17 TRIAL
220004343 220001756 null 84.8 Palliative (P) 2013-03-09 2013-03-24 Trial Unspecified Y N 220025847 TRIAL
220004344 220001756 1.46 74.6 Palliative (P) 2015-11-08 2015-11-08 Trial Unspecified 01 null 220025847 TRIAL